BIO-key International, Inc.
BKYI
$0.79
$0.0212.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -31.82% | 87.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -31.82% | 87.93% | |||
| Cost of Revenue | -43.58% | 77.32% | |||
| Gross Profit | -28.56% | 91.09% | |||
| SG&A Expenses | 15.26% | -17.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.17% | -2.51% | |||
| Operating Income | -118.40% | 64.91% | |||
| Income Before Tax | -90.46% | 55.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -87.35% | 55.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -87.35% | 55.67% | |||
| EBIT | -118.40% | 64.91% | |||
| EBITDA | -144.17% | 69.11% | |||
| EPS Basic | -16.78% | 60.99% | |||
| Normalized Basic EPS | -18.70% | 60.99% | |||
| EPS Diluted | -16.78% | 60.99% | |||
| Normalized Diluted EPS | -18.70% | 60.99% | |||
| Average Basic Shares Outstanding | 60.46% | 13.63% | |||
| Average Diluted Shares Outstanding | 60.46% | 13.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||